The type 1-transmembrane protein LMAN1 (ERGIC-53) forms a complex with the soluble protein MCFD2 and cycles between the endoplasmic reticulum (ER) and the ER-Golgi intermediate compartment (ERGIC). Mutations in either LMAN1 or MCFD2 cause the combined deficiency of factor V (FV) and factor VIII (FVIII; F5F8D), suggesting an ER-to-Golgi cargo receptor function for the LMAN1-MCFD2 complex. Here we report the analysis of LMAN1-deficient mice. Levels of plasma FV and FVIII, and platelet FV, are all reduced to ϳ 50% of wild-type in Lman1 ؊/؊ mice, compared with the 5%-30% levels typically observed in human F5F8D patients. Despite previous reports identifying cathepsin C, cathepsin Z, and ␣1-antitrypsin as additional potential cargoes for LMAN1, no differences were observed between wildtype and Lman1 ؊/؊ mice in the levels of cathepsin C and cathepsin Z in liver lysates or ␣1-antitrypsin levels in plasma. LMAN1 deficiency had no apparent effect on COPII-coated vesicle formation in an in vitro assay. However, the ER in Lman1 ؊/؊ hepatocytes is slightly distended, with significant accumulation of ␣1-antitrypsin and GRP78. An unexpected, partially penetrant, perinatal lethality was observed for Lman1 ؊/؊ mice, dependent on the specific inbred strain genetic background, suggesting a potential role for other, as yet unidentified LMAN1-dependent cargo proteins. (Blood. 2011;118(12):3384-3391)